Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
5
×
boston blog main
life sciences
national blog main
boston top stories
clinical trials
deals
fda
investing
san francisco blog main
startups
drug delivery
medical device
new york blog main
san diego blog main
vc
480 biomedical
akouos
arrowmark partners
arsenal medical
astellas pharmaceuticals
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
biotech ipos
bob langer
boston university
california institute for biomedical research
chronic rhinosinusitis
congenital hyperinsulinism
covid-19
dacogen
decibel therapeutics
decitabine
dexcom
diabetes
dna
dyne therapeutics
What
developing
5
×
therapeutics
ipo
medicines
million
biotech
company
drug
new
raised
startup
tests
treat
affects
aims
americans
approach
approved
based
beta
bionics
blood
brings
called
closed
date
debut
debuts
device
diabetes
disorders
driven
drugs
dyne
dyne’s
epigenetic
epigenetics
fda
field
flagship’s
Language
unset
Current search:
boston
×
developing
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
